Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
- PMID: 10084573
- DOI: 10.1210/jcem.84.3.5565
Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Abstract
Women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, especially those patients with the salt-losing form, have decreased fertility rates. Pregnancy experience in this population is limited. We report the pregnancy outcomes and serial measurements of maternal serum steroid levels in four women with classic 21-hydroxylase deficiency, three of whom were female pseudohermaphrodites with the salt-losing form. These glucocorticoid-treated women gave birth to four healthy female newborns with normal female external genitalia, none of whom were affected with 21-hydroxylase deficiency. In three women, circulating androgen levels increased during gestation, but remained within the normal range for pregnancy during glucocorticoid therapy. In the fourth patient, androgen levels were strikingly elevated during gestation despite increasing the dose of oral prednisone from 5 to 15 mg/day (two divided doses). Notwithstanding the high maternal serum concentration of androgens, however, placental aromatase activity was sufficient to prevent masculinization of the external genitalia of the female fetus and quite likely the fetal brain, consistent with the idea that placental aromatization of androgens to estrogens is the principal mechanism that protects the female fetus from the masculinizing effects of maternal hyperandrogenism. These four patients highlight key issues in the management of pregnancy in women with 21-hydroxylase deficiency, particularly the use of endocrine monitoring to assess adrenal androgen suppression in the mother, especially when the fetus is female. Recommendations for the management of pregnancy and delivery in these patients are discussed.
Similar articles
-
Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.J Clin Endocrinol Metab. 1999 Sep;84(9):3129-34. doi: 10.1210/jcem.84.9.5976. J Clin Endocrinol Metab. 1999. PMID: 10487675
-
[Congenital adrenal hyperplasia and pregnancy].Rev Paul Med. 1989 Mar-Apr;107(2):88-92. Rev Paul Med. 1989. PMID: 2629059 Portuguese.
-
[Pregnancy outcomes of eight pregnant women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].Zhonghua Fu Chan Ke Za Zhi. 2012 Sep;47(9):651-4. Zhonghua Fu Chan Ke Za Zhi. 2012. PMID: 23141285 Chinese.
-
[Prenatal diagnosis and treatment of adrenogenital syndrome. Prevent virilization of female fetuses].Lakartidningen. 1997 Dec 10;94(50):4781-6. Lakartidningen. 1997. PMID: 9445959 Review. Swedish.
-
Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia.Endocrinol Metab Clin North Am. 2001 Mar;30(1):207-29. doi: 10.1016/s0889-8529(08)70027-6. Endocrinol Metab Clin North Am. 2001. PMID: 11344937 Review.
Cited by
-
Growth and reproductive outcomes in congenital adrenal hyperplasia.Int J Pediatr Endocrinol. 2010;2010:298937. doi: 10.1155/2010/298937. Epub 2010 Feb 1. Int J Pediatr Endocrinol. 2010. PMID: 20148087 Free PMC article.
-
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.J Clin Endocrinol Metab. 2018 Nov 1;103(11):4043-4088. doi: 10.1210/jc.2018-01865. J Clin Endocrinol Metab. 2018. PMID: 30272171 Free PMC article.
-
The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.Endocr Rev. 2011 Feb;32(1):81-151. doi: 10.1210/er.2010-0013. Epub 2010 Nov 4. Endocr Rev. 2011. PMID: 21051590 Free PMC article. Review.
-
Maternal 11-Ketoandrostenedione Rises Through Normal Pregnancy and Is the Dominant 11-Oxygenated Androgen in Cord Blood.J Clin Endocrinol Metab. 2022 Feb 17;107(3):660-667. doi: 10.1210/clinem/dgab793. J Clin Endocrinol Metab. 2022. PMID: 34718643 Free PMC article.
-
Adrenal disorders in pregnancy.Nat Rev Endocrinol. 2012 Nov;8(11):668-78. doi: 10.1038/nrendo.2012.155. Epub 2012 Sep 11. Nat Rev Endocrinol. 2012. PMID: 22965163 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases